INSERM (Institut National de la Sante et de la Recherche Medicale);Assistance Publique - Hopitaux De Paris;SORBONNE UNIVERSITE
发明人:
David Klatzmann,David Saadoun,Patrice Cacoub,Michèle Rosenzwajg,Eliane Piaggio,Gilbert Bensimon,Claude Bernard
申请号：
US16361902
公开号：
US20190351023A1
申请日:
2019.03.22
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.
